Market Overview

CORRECTION: Oppenheimer Initiates Coverage on Tonix Pharmaceuticals at Outperform, Announces $18.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CNS

DateFirmActionFromTo
Jan 2018Keefe Bruyette & WoodsDowngradesMarket PerformUnderperform
Jan 2018Gabelli & Co.DowngradesBuyHold
Oct 2017Bank of AmericaMaintainsUnderperform

View More Analyst Ratings for CNS
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (CNS + TNXP)